Globavir Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Globavir Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10974
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates for the treatment of cancer and infectious diseases. The company’s lead product includes GBV006, a potent anti-infective for Ebola, development of dengue diagnostics and small molecule drugs to treat cancer and infection diseases. It also offers PanGlob, MulGlob and DenGlo for accurate diagnostics. The company has research collaborations with other pharmaceutical companies. Globavir is headquartered in Los Altos, California, the US.

Globavir Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Globavir Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Globavir Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Globavir Biosciences Raises USD0.1 Million in Venture Financing 11
Globavir Biosciences Secures USD4 Million in Venture Funding 12
Partnerships 13
Globavir Biosciences Enters into Agreement with Viral Research and Experimental Medicine Centre 13
Globavir Enters into Co-Development Agreement with Biomanguinhos 14
Licensing Agreements 15
Sorrento Therapeutics Enters into Licensing Agreement with Globavir Biosciences 15
Globavir Enters into Licensing Agreement with Stanford University 16
Globavir Biosciences Inc – Key Competitors 17
Globavir Biosciences Inc – Key Employees 18
Globavir Biosciences Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Globavir Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Globavir Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Globavir Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Globavir Biosciences Raises USD0.1 Million in Venture Financing 11
Globavir Biosciences Secures USD4 Million in Venture Funding 12
Globavir Biosciences Enters into Agreement with Viral Research and Experimental Medicine Centre 13
Globavir Enters into Co-Development Agreement with Biomanguinhos 14
Sorrento Therapeutics Enters into Licensing Agreement with Globavir Biosciences 15
Globavir Enters into Licensing Agreement with Stanford University 16
Globavir Biosciences Inc, Key Competitors 17
Globavir Biosciences Inc, Key Employees 18

List of Figures
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Globavir Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Globavir Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Globavir Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Constellium NV:企業の戦略・SWOT・財務情報
    Constellium NV - Strategy, SWOT and Corporate Finance Report Summary Constellium NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Shangri-La Hotels (Malaysia) Berhad:企業の戦略・SWOT・財務情報
    Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • BYD Co Ltd (1211):企業の財務・戦略的SWOT分析
    BYD Co Ltd (1211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sinovac Biotech Ltd (SVA):企業の財務・戦略的SWOT分析
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, a an inactivated hepatitis A vaccine; bilive, a combined inactivated hepatitis A and B vaccine; anflu, a split viron influenz …
  • ProMIS Neurosciences Inc (PMN):企業の製品パイプライン分析
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of neurodegenerative disorders. Its major products include tests functional assa …
  • Dartmouth College:製薬・医療:M&Aディール及び事業提携情報
    Summary Dartmouth College (Dartmouth) is an educational institution that offers education and research services. The institute provides various programs in the field of art history, languages and literatures, english and creative writing, film and media studies, sociology, psychological and brain sc …
  • China Haisheng Juice Holdings Co Ltd:企業の戦略・SWOT・財務分析
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • CellaVision AB (CEVI)-医療機器分野:企業M&A・提携分析
    Summary CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automate …
  • Emerson Electric Co (EMR):石油・ガス:M&Aディール及び事業提携情報
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • Bajaj Auto Ltd:企業の戦略・SWOT・財務情報
    Bajaj Auto Ltd - Strategy, SWOT and Corporate Finance Report Summary Bajaj Auto Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Egdon Resources Plc (EDR):石油・ガス:M&Aディール及び事業提携情報
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • Afrimat Ltd:企業の戦略・SWOT・財務情報
    Afrimat Ltd - Strategy, SWOT and Corporate Finance Report Summary Afrimat Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Dais Analytic Corps (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Analytic Corps (Dais) is an alternative energy company that provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV an …
  • Coastal Contacts Inc-医療機器分野:企業M&A・提携分析
    Summary Coastal Contacts Inc (Coastal Contacts), a subsidiary of Essilor International is an online retailer that markets eye care products. The company's products include eyeglasses, contact lenses, sunglasses, vision care accessories, and others. Its contact lenses comprise daily wear colour lense …
  • Mega First Corporation Bhd (MFCB):企業の財務・戦略的SWOT分析
    Summary Mega First Corporation Bhd (MFCB) is a diversified company. The company operates through its business divisions such as power generation, resources, and property development and investment. Its power generation business builds, owns, operates and maintains coal-fired heat and power plant. MF …
  • CLP Holdings Limited:企業の戦略・SWOT・財務分析
    CLP Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CLP Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Crown Resorts Ltd:戦略・SWOT・企業財務分析
    Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tenaska Inc-エネルギー分野:企業M&A・提携分析
    Summary Tenaska, Inc. (Tenaska) is an independent energy company that develops, designs, finances, and manages and operates non-utility power plants. It purchases and sells natural gas, electric capacity, energy, and renewable energy products; acquires, manages, and optimizes natural gas, and electr …
  • Shadin Avionics LP:企業の戦略・SWOT・財務分析
    Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report Summary Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Episurf Medical AB (EPIS B):企業の財務・戦略的SWOT分析
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. The company offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, E …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆